文献速递妇产影像技术与安全US

妊娠19-24周子痫前期联合筛查后的妊娠管理

Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation.
PubMed 文献 · Ultrasound Obstet Gynecol · 2018-06-25

该前瞻性观察研究纳入16 254例单胎妊娠,在19-24周用母体因素联合MAP、UtA-PI、PlGF和sFlt-1计算子痫前期风险,将人群分为高、中、低风险组进行分层管理;高风险组约占总人群1%,可包含100%的32周前子痫前期病例(母体因素+MAP+UtA-PI+PlGF±sFlt-1筛查时)。

要点

  • 19-24周联合筛查可将妊娠分层为24-31周需密切监测血压和蛋白尿的高风险组及32周需再评估者。
  • 高风险组约占人群1%,联合母体因素、MAP、UtA-PI和PlGF(±sFlt-1)可包含100%的32周前子痫前期病例。
  • 32+0至35+6周子痫前期病例中,约90%落在32周需再评估的人群内(联合筛查时该人群约占10%)。

核心结论

  • 在新型妊娠保健金字塔中,19-24周评估子痫前期风险可将人群分层为24-31周需强化监测者及32周需再评估者。

研究设计与样本

  • 前瞻性观察研究,纳入16 254例单胎妊娠,于19-24周常规超声检查时行母体因素、MAP、UtA-PI、PlGF和sFlt-1联合筛查,采用竞争风险模型计算32周前和36周前子痫前期分娩风险。

诊断标准与关键数值

  • 采用竞争风险模型结合母体特征与病史的先验分布及MAP、UtA-PI、PlGF、sFlt-1的MoM值计算风险;以32周前子痫前期风险>1/25和36周前风险>1/150为高风险组切点。

临床应用与阅片要点

  • 高风险组(约占总人群1%)需在24-31周密切监测高血压和蛋白尿;中风险组及高风险组中未分娩者于32周再评估,以识别需在32-35周密切监测者;所有妊娠于36周再评估以制定后续监测和分娩计划。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To estimate the patient-specific risk of pre-eclampsia (PE) at 19-24 weeks' gestation by maternal factors and combinations of mean arterial pressure (MAP), uterine artery pulsatility index (UtA-PI), serum placental growth factor (PlGF) and serum soluble fms-like tyrosine kinase-1 (sFlt-1). On the basis of the risk of PE, the women would be stratified into high-, intermediate- and low-risk management groups. The high-risk group would require close monitoring for high blood pressure and proteinuria at 24-31 weeks. The intermediate-risk group, together with the undelivered pregnancies from the high-risk group, would have reassessment of risk for PE at 32 weeks to identify those who would require close monitoring for high blood pressure and proteinuria at 32-35 weeks. All pregnancies would have reassessment of risk for PE at 36 weeks to define the plan for further monitoring and delivery.

METHODS: This was a prospective observational study of women attending for an ultrasound scan at 19-24 weeks as part of routine pregnancy care. Patient-specific risks of delivery with PE at < 32 and at < 36 weeks' gestation were calculated using the competing-risks model to combine the prior distribution of gestational age at delivery with PE, obtained from maternal characteristics and medical history, with multiples of the median (MoM) values of MAP, UtA-PI, PlGF and sFlt-1. Different risk cut-offs were used to vary the proportion of the population stratified into high-, intermediate- and low-risk groups, and the performance of screening for delivery with PE at < 32 weeks' gestation and at 32 + 0 to 35 + 6 weeks was estimated.

RESULTS: The study population of 16 254 singleton pregnancies included 467 (2.9%) that subsequently developed PE (23 delivered at < 32 weeks, 58 delivered at 32 + 0 to 35 + 6 weeks and 386 delivered at ≥ 36 weeks). Using a risk of > 1 in 25 for PE at < 32 weeks' gestation and risk of > 1 in 150 for PE at < 36 weeks, the proportion of the population stratified into the high-risk group was about 1% of the total, and the proportion of cases of PE at < 32 weeks' gestation contained within this high-risk group varied from about 35% with screening by maternal factors and MAP, to 78% with maternal factors, MAP and UtA-PI, and up to 100% with maternal factors, MAP, UtA-PI and PlGF, with or without sFlt-1. Similarly, the proportion of the population requiring reassessment of risk at 32 weeks' gestation and the proportion of cases of PE at 32 + 0 to 35 + 6 weeks contained within this population varied, respectively, from about 18% and 79% with screening by maternal factors and MAP, to 10% and 90% with maternal factors, MAP, UtA-PI and PlGF, with or without sFlt-1.

CONCLUSION: In the new pyramid of pregnancy care, assessment of risk for PE at 19-24 weeks' gestation can stratify the population into those requiring intensive monitoring at 24-31 weeks and those in need of reassessment at 32 weeks. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Litwinska M, Syngelaki A, Wright A, et al. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation. Ultrasound Obstet Gynecol. 2018. PMID: 29943498. doi:10.1002/uog.19099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。